Carbamazepine Tablet
Product Images NDC 70518-2242

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-2242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Carbamazepine is a medication available in tablet form with a strength of 200 mg. This batch consists of 180 tablets and was repackaged by RemedyRepack Inc., Indiana, PA 15701. The medication was manufactured by Taro Pharma in Haifa Bay, Israel, and bears the Source NDC 51672-4005-01. It is essential to keep this medication out of the reach of children, and the directions for use can be found in the package insert. The lot number and expiration date are not available. The medication should be stored at a temperature between 20-26°C (63-77°F), with excursions allowed up to 15-30°C (59-86°F), as per USP guidelines.*
FDA Label Image

Carbamazepine 200mg 70518 2242 01

Carbamazepine 200mg 70518 2242 01
carBAMazepine is a medication available in the form of 200mg tablets. The tablets come in a pack size of 100 and are manufactured by Taro Pharma, Israel. The medicine should be stored at a temperature between 20-26°C (63-77°F) while excursions are allowed between 15-30°C (59-86°F). The package insert should be consulted for directions on usage of the medicine. The medicine has been repackaged by RemedyRepack Inc. in Indiana.*
FDA Label Image

Carbamazepine 200mg 70518 2242 02

Carbamazepine 200mg 70518 2242 02
CarBAMazepine is a prescription medication that comes in a single HD2 1 unit. It is exclusively for RX use only. The medicine is repackaged by RemedyRepack Inc. in Indiana, PA. The Manufacturer of CarBAMazepine is Taro Pharma located in Haifa Bay, Israel. One package contains product lot # and NDC#70518-2242-02, and its source NDC is 51672-4005- 01. The medicine should be stored in a cool place with excursions of 15-30 degrees Celsius (59-86 degrees Fahrenheit) being permissible. The direction for use is specified in the package insert, and it has to be kept out of reach of children.*
FDA Label Image

Carbamazepine 200mg 70518 2242 03

Carbamazepine 200mg 70518 2242 03
Carbamazepine is a prescription drug that comes in a bottle of 30 tablets with the strength of HD2. It is manufactured by Taro Pharma in Haifa Bay, Israel. The National Drug Code for this product is 70518-2242-03 and the packaging has instructions to store the product at 20-26°C (63-77°F) with excursions to 15-30°C (59-86°F) allowed. The product should be kept out of the reach of children. The packaging includes the LOT number and source NDC number but the expiration date is not available. Directions for use can be found in the package insert. The product has been repackaged by RemedyRepack Inc. based in Indiana, PA 15701.*
FDA Label Image

Carbamazepine 200mg 70518 2242 04

Carbamazepine 200mg 70518 2242 04
carBAMazepine is a tablet of 200 mg, and the quantity of tablets available is 100. The manufacturer of this tablet is Taro Pharma, located in Haifa Bay, Israel 26110. The NDC number for this tablet is 70518-2242-04, and the source NDC is 51672-4005-02. The lot number and expiration date are not available. The tablet should be stored between 20-26°C (63-77°F), and excursions permitted are between 15-30°C (59-86°F) [See USP]. To check the directions to use this tablet follow the package insert. The Repackaging of this tablet is done by RemedyRepack Inc. and should be kept out of children's reach.*
FDA Label Image

Carbamazepine 200mg 70518 2242 05

Carbamazepine 200mg 70518 2242 05
This is a pharmaceutical medication called Carbamazepine, which is available only with a prescription. The bottle contains 1 HD2 (no further information on what this refers to). The National Drug Code (NDC) for the product is 70518-2242-05, and its lot number and expiration date are not provided. The product was originally manufactured by Taro Pharma in Haifa Bay, Israel 26110, and repackaged by a company called RemedyRepack Inc. The bottle should be stored between 20-26°C (63-77°F), with permissible excursions between 15-30°C (59-86°F). There are no further usage instructions except to consult the package insert. The label also contains a warning to keep the medication out of reach of children.*
FDA Label Image

Carbamazepine 200mg 70518 2242 06

Carbamazepine 200mg 70518 2242 06
CarBAMazepine is a tablet medication manufactured by Taro Pharma, Haifa Bay, Israel. The tablets are 200 mg each, and the quantity in the package is 100. The medication is labeled with an NDC number of 70518-2242-06 and has an expiration date and lot number for tracking purposes. The recommended storage temperature is between 20-26°C (63-77°F), with allowable excursions to 15-30°C (59-86°F), and the package insert should be consulted for usage directions. Repackaging has been done by RemedyRepack Inc, Indiana, PA 15701.*
FDA Label Image

Carbamazepine 200mg 70518 2242 07

Carbamazepine 200mg 70518 2242 07
This is a description of a medication called Carbamazepine. It is a prescription drug marked as RX only, and the bottle contains one HD2 tablet. It provides information about the drug's expiration date, lot number, and source NDC, which is from Taro Pharma in Haifa Bay, Israel. The text also includes instructions to keep the medicine out of a child's reach and to see the package insert for the dosage directions. RemedyRepack Inc. in Indiana repackaged the Carbamazepine tablets, and the recommended storage temperature is 20-26°C (63-77°F) with permitted excursions up to 15-30°C (59-86°F) [See USP].*
FDA Label Image

Chemical Structure (Carbamazepine 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.